(Total Views: 542)
Posted On: 11/11/2020 2:54:37 PM
Post# of 153942
“Ooooo.. he said 'Dividend,' followed by 'Dollars'...”
He’s being very overly optimistic about the amount of dividend per share in the near future (which is his personality).
The average dividend on the S&P and DJIA is around 3.25%. If we use the 3.25% and apply it to NP’s statements, the share price would need to be in the $30-60 range for a dividend of $1-2 per share to be given (and CYDY would need the $1.2 billion in cash to do so). I’m unsure of what a COVID EUA would do for the share price or revenues, but I’d prefer CYDY keep the $1.2 billion or so in dividends NP is suggesting and instead use it to fund clinical trials. CYDY can then pay me large dividends when leronlimab is approved for multiple indications and is brining in billions, if not tens of billions, per year.
He’s being very overly optimistic about the amount of dividend per share in the near future (which is his personality).
The average dividend on the S&P and DJIA is around 3.25%. If we use the 3.25% and apply it to NP’s statements, the share price would need to be in the $30-60 range for a dividend of $1-2 per share to be given (and CYDY would need the $1.2 billion in cash to do so). I’m unsure of what a COVID EUA would do for the share price or revenues, but I’d prefer CYDY keep the $1.2 billion or so in dividends NP is suggesting and instead use it to fund clinical trials. CYDY can then pay me large dividends when leronlimab is approved for multiple indications and is brining in billions, if not tens of billions, per year.
(2)
(1)
